Directory
>
Karl Mcevoy
Karl Mcevoy
Vice President, eCOA and Patient Technologies | YPrime
Ireland
Karl Mcevoy
Summary
Karl Mcevoy is a seasoned scientist and business leader with extensive experience in the pharmaceutical industry, particularly in patient-centered outcomes and digital health technologies. Currently serving as Vice President at YPrime, he has a proven track record of leading global clinical trials and collaborating with top pharmaceutical companies. With a Ph.D. from University College Dublin, Karl's expertise spans agile methodologies, drug development, and clinical research. His leadership style emphasizes the importance of the patient's voice in healthcare decisions. A diligent and detail-oriented professional, he has successfully influenced cross-functional initiatives that drive process improvements and innovative solutions. Karl's commitment to excellence and strategic thinking positions him as a key player in shaping the future of healthcare through technology and research.
Karl Mcevoy
Work Experience
Vice President, eCOA and Patient Technologies at
YPrime
April 2024 - Present
Product Director, Decentralised Trial Technology at
YPrime
May 2021 - April 2024
Principal PCOR Scientist at
ROCHE LEON HOLDINGS
June 2019 - May 2021
Senior Principal PCOR Scientist at
ROCHE LEON HOLDINGS
May 2020 - May 2021
Senior Outcomes Measurement Scientist at
ROCHE LEON HOLDINGS
April 2017 - June 2019
Manager, Health Outcomes at
Crf Health
May 2014 - April 2017
Health Outcomes analyst at
Crf Health
November 2012 - May 2014
Karl Mcevoy
Education
University College Dublin, Doctor Of Philosophy (Ph.D.)
January 2006 - January 2012
University College Dublin, Bachelor's Degree (B.Sc Honors)
January 2001 - January 2006
Frequently Asked Questions about Karl Mcevoy
What is Karl Mcevoy email address?
Karl Mcevoy's primary email address is *******@yprime.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Karl Mcevoy work for?
Karl Mcevoy is a Vice President, eCOA and Patient Technologies at YPrime, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Karl Mcevoy graduated from?
Karl Mcevoy holds a degree in Therapeutics, Conversion Mechanisms And Novel Interactions Of The Prion Protein. from University College Dublin.
How can I directly contact Karl Mcevoy?
To contact Karl Mcevoy directly, you can use the email address *******@yprime.com. Complete contact information is available upon registration with Muraena.
Who is Karl Mcevoy?
Karl Mcevoy is a seasoned scientist and business leader with extensive experience in the pharmaceutical industry, particularly in patient-centered outcomes and digital health technologies. Currently serving as Vice President at YPrime, he has a proven track record of leading global clinical trials and collaborating with top pharmaceutical companies. With a Ph.D. from University College Dublin, Karl's expertise spans agile methodologies, drug development, and clinical research. His leadership style emphasizes the importance of the patient's voice in healthcare decisions. A diligent and detail-oriented professional, he has successfully influenced cross-functional initiatives that drive process improvements and innovative solutions. Karl's commitment to excellence and strategic thinking positions him as a key player in shaping the future of healthcare through technology and research.
Karl`s contact details
*******@yprime.com
***********@ucd.ie
***********@roche.com
Colleagues
Vice President IRT Operations
Chief Compliance Officer
Vice President, Strategic Partnerships
Senior Vice President, Customer Experience and Data Science
Chief Financial Officer
Executive Director, eCOA Solutions Delivery
Senior Vice President, Operations
CEO & Co-Founder, DJAWN, LLC
Seed Investor
Senior Vice President, eCOA Strategy